Back |
home / stock / rlmd / rlmd message board
Subject | By | Source | When |
---|---|---|---|
@Relmada Therapeutics: A Promising Depression Focused Player For 2020 | VictorMasonIsRight | investorshub | 02/18/2020 10:54:26 AM |
znewcar1: RLMD 36% v1,3M c47.18 f10M H 49.8 EOD push | znewcar1 | investorshangout | 12/04/2019 9:24:24 PM |
whytestocks: $RLMD News Article - Relmada Therapeutics Announces Proposed Public Offering of Common | whytestocks | investorshangout | 12/03/2019 9:20:42 PM |
znewcar1: RLMD 134% v2,2M c26.20 f9,8M H 36 S@19 then bounced around VWAP | znewcar1 | investorshangout | 10/15/2019 8:29:22 PM |
whytestocks: $RLMD News Article - Relmada Therapeutics to Present at LD Micro Invitational Conferenc | whytestocks | investorshangout | 06/03/2019 7:00:40 PM |
znewcar1: 32.35% V16K c3:58 f30,266,373 Gap up and ran | znewcar1 | investorshangout | 03/05/2019 3:05:47 AM |
Griftersbro: This stock is so undervalued it's silly | Griftersbro | investorshangout | 02/14/2017 3:15:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Relmada Therapeutics Inc. Company Name:
RLMD Stock Symbol:
OTCMKTS Market:
Relmada Therapeutics Inc. Website:
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry PR Newswire CORAL GABLES, Fla. , June 18, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage b...
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire CORAL GABLES, Fla. , June 10, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of t...
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference PR Newswire CORAL GABLES, Fla. , June 3, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the cent...